304 related articles for article (PubMed ID: 27036135)
1. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
[TBL] [Abstract][Full Text] [Related]
2. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
Hehlgans S; Eke I; Cordes N
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
[TBL] [Abstract][Full Text] [Related]
3. FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.
Pifer PM; Yang L; Kumar M; Xie T; Frederick M; Hefner A; Beadle B; Molkentine D; Molkentine J; Dhawan A; Abdelhakiem M; Osman AA; Leibowitz BJ; Myers JN; Pickering CR; Sandulache VC; Heymach J; Skinner HD
Clin Cancer Res; 2024 Jan; 30(1):187-197. PubMed ID: 37819945
[TBL] [Abstract][Full Text] [Related]
4. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
5. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
6. BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer.
Liu X; Kumar M; Yang L; Molkentine DP; Valdecanas D; Yu S; Meyn RE; Heymach JV; Skinner HD
Clin Cancer Res; 2018 Feb; 24(3):600-607. PubMed ID: 29113987
[No Abstract] [Full Text] [Related]
7. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
8. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of radioresistance in head and neck squamous cell carcinomas.
Avril D; Foy JP; Bouaoud J; Grégoire V; Saintigny P
Int J Radiat Biol; 2023; 99(4):583-593. PubMed ID: 35930497
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer.
Skinner HD; Giri U; Yang LP; Kumar M; Liu Y; Story MD; Pickering CR; Byers LA; Williams MD; Wang J; Shen L; Yoo SY; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
Clin Cancer Res; 2017 Jun; 23(11):2713-2722. PubMed ID: 28476872
[No Abstract] [Full Text] [Related]
11. HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.
Busch CJ; Kriegs M; Laban S; Tribius S; Knecht R; Petersen C; Dikomey E; Rieckmann T
Radiother Oncol; 2013 Sep; 108(3):495-9. PubMed ID: 23932155
[TBL] [Abstract][Full Text] [Related]
12. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.
Moeller BJ; Yordy JS; Williams MD; Giri U; Raju U; Molkentine DP; Byers LA; Heymach JV; Story MD; Lee JJ; Sturgis EM; Weber RS; Garden AS; Ang KK; Schwartz DL
Clin Cancer Res; 2011 Apr; 17(7):2035-43. PubMed ID: 21349997
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive pan-cancer analysis of 33 human cancers reveals immunotherapeutic value of focal adhesion tyrosine kinase.
Shi Y; Ju M; Zhang Y; Liang L; Sun X; Di X
Medicine (Baltimore); 2024 Mar; 103(12):e37362. PubMed ID: 38518034
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
16. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
[TBL] [Abstract][Full Text] [Related]
17. Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
Enzenhofer E; Parzefall T; Haymerle G; Schneider S; Kadletz L; Heiduschka G; Pammer J; Oberndorfer F; Wrba F; Loader B; Grasl MC; Perisanidis C; Erovic BM
PLoS One; 2016; 11(12):e0167665. PubMed ID: 27918595
[TBL] [Abstract][Full Text] [Related]
18. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
19. IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.
Lehman CE; Spencer A; Hall S; Shaw JJP; Wulfkuhle J; Petricoin EF; Bekiranov S; Jameson MJ; Gioeli D
Sci Rep; 2021 May; 11(1):10826. PubMed ID: 34031486
[TBL] [Abstract][Full Text] [Related]
20. Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications.
Perri F; Pacelli R; Della Vittoria Scarpati G; Cella L; Giuliano M; Caponigro F; Pepe S
Head Neck; 2015 May; 37(5):763-70. PubMed ID: 24995469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
